Loss of ceramide synthase 3 causes lethal skin barrier disruption

Richard Jennemann(German Cancer Research Center), Mariona Rabionet, Karin Gorgas(Institute of Cell Biology and Neurobiology), Sharon Epstein(University of Geneva), Alexander H. Dalpke(Institute of Medical Microbiology and Hygiene), Ulrike Rothermel, Aline Bayerle, Franciscus van der Hoeven(German Cancer Research Center), Silke Imgrund(University of Bonn), Joachim Kirsch(Institute of Cell Biology and Neurobiology), Walter Nickel, Klaus Willecke(University of Bonn), Howard Riezman(University of Geneva), Hermann-Josef Gröne, Roger Sandhoff(Technische Hochschule Mannheim)
Human Molecular Genetics
October 28, 2011
Cited by 273Open Access
Full Text

Abstract

The stratum corneum as the outermost epidermal layer protects against exsiccation and infection. Both the underlying cornified envelope (CE) and the intercellular lipid matrix contribute essentially to these two main protective barriers. Epidermis-unique ceramides with ultra-long-chain acyl moities (ULC-Cers) are key components of extracellular lipid lamellae (ELL) and are bound to CE proteins, thereby contributing to the cornified lipid envelope (CLE). Here, we identified human and mouse ceramide synthase 3 (CerS3), among CerS1-6, to be exclusively required for the ULC-Cer synthesis in vitro and of mouse CerS3 in vivo. Deficiency of CerS3 in mice results in complete loss of ULC-Cers (≥C26), lack of continuous ELL and a non-functional CLE. Consequently, newborn mutant mice die shortly after birth from transepidermal water loss. Mutant skin is prone to Candida albicans infection highlighting ULC-Cers to be pivotal for both barrier functions. Persistent periderm, hyperkeratosis and deficient cornification are hallmarks of mutant skin demonstrating loss of Cers to trigger a keratinocyte maturation arrest at an embryonic pre-barrier stage.


Related Papers

No related papers found

Powered by citation graph analysis